[1]姜洪苗.高危型HPV-E6/E7mRNA检测在宫颈病变筛查中的临床价值[J].医学信息,2021,34(22):163-165.[doi:10.3969/j.issn.1006-1959.2021.22.050]
　JIANG Hong-miao.Clinical Value of High-risk HPV-E6/E7 mRNA Detection in Cervical Lesions Screening[J].Medical Information,2021,34(22):163-165.[doi:10.3969/j.issn.1006-1959.2021.22.050]
点击复制

高危型HPV-E6/E7mRNA检测在宫颈病变筛查中的临床价值()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
34卷
期数:
2021年22期
页码:
163-165
栏目:
诊疗技术
出版日期:
2021-11-15

文章信息/Info

Title:
Clinical Value of High-risk HPV-E6/E7 mRNA Detection in Cervical Lesions Screening
文章编号:
1006-1959（2021）22-0163-03
作者:
姜洪苗
（南京医科大学第二附属医院妇产科，江苏 南京 210000）
Author(s):
JIANG Hong-miao
(Department of Obstetrics and Gynecology,the Second Affiliated Hospital of Nanjing Medical University,Nanjing 210000,Jiangsu,China)
关键词:
高危型人乳头瘤病毒; mRNA检测; 宫颈病变
Keywords:
High-risk human papillomavirus; mRNA detection; Cervical lesions
分类号:
R737.33
DOI:
10.3969/j.issn.1006-1959.2021.22.050
文献标志码:
A
摘要:
目的 分析高危型人乳头瘤病毒（HR-HPV）-E6/E7mRNA检测在宫颈病变筛查中的临床价值。方法 选取2020年2月-2021年2月南京医科大学第二附属医院共80例就诊患者作为研究对象，所有患者均接受阴道镜活检、HPV分型检测以及HR-HPV-E6/E7 mRNA检测，并以阴道镜活检病理结果作为金标准，分析HPV分型检测以及HR-HPV-E6/E7 mRNA检测结果，及HR-HPV-E6/E7 mRNA检测与宫颈病变病理分级的相关性。结果 HPV检测显示阳性44例，占比55.00%；阴性36例，占比45.00%；阳性中正常或炎症占比低于阴性，CIN1、CIN2以及CIN3占比均高于阴性，差异有统计学意义（P＜0.05）；阳性与阴性ICC占比比较，差异无统计学意义（P＞0.05）。HR-HPV-E6/E7 mRNA检测显示阳性42例，占比52.50%；阴性38例，占比47.50%；阳性正常或炎症占比低于阴性，CIN1、CIN2以及CIN3均高于阴性，差异有统计学意义（P＜0.05）；阳性与阴性ICC占比比较，差异无统计学意义（P＞0.05）。HPV阳性率与HR-HPV-E6/E7 mRNA阳性率比较，差异无统计学意义（P＞0.05）。Spearman相关性分析显示，HR-HPV-E6/E7 mRNA阳性与CIN1、CIN2以及CIN3呈正相关（r=0.670、0.510、0.600，P＜0.05）。结论 HR-HPV-E6/E7 mRNA检测阳性与宫颈病变病理结果密切相关，有利于临床医师判断患者病变的严重程度，且对患者预后具有一定的指导意义。
Abstract:
Objective To analyze the clinical value of high-risk human papillomavirus (HR-HPV)-E6/E7 mRNA in the screening of cervical lesions.Methods A total of 80 patients in the Second Affiliated Hospital of Nanjing Medical University from February 2020 to February 2021 were selected as the research objects. All patients underwent colposcopy biopsy, HPV genotyping and HR-HPV-E6/E7 mRNA detection. The pathological results of colposcopy biopsy were used as the gold standard to analyze the results of HPV genotyping and HR-HPV-E6/E7 mRNA detection, and the correlation between HR-HPV-E6/E7 mRNA detection and pathological grading of cervical lesions.Results HPV test showed positive in 44 cases, accounting for 55.00%; negative 36 cases, accounting for 45.00%; the proportion of normal or inflammation in positive was lower than that in negative, and the proportion of CIN1, CIN2 and CIN3 was higher than that in negative, the difference was statistically significant (P<0.05). HR-HPV-E6/E7 mRNA detection showed 42 positive cases, accounting for 52.50%; negative 38 cases, accounting for 47.50%; the proportion of positive normal or inflammation was lower than negative, CIN1, CIN2 and CIN3 were higher than negative, the difference was statistically significant (P<0.05). There was no significant difference between the positive rates of HPV and HR-HPV-E6/E7 mRNA (P>0.05). Spearman correlation analysis showed that HR-HPV-E6/E7 mRNA positive was positively correlated with CIN1, CIN2 and CIN3 (r=0.670, 0.510, 0.600, P<0.05).Conclusion The positive detection of HR-HPV-E6/E7 mRNA is closely related to the pathological results of cervical lesions, which is helpful for clinicians to judge the severity of patients’, lesions, and has certain guiding significance for the prognosis of patients.

参考文献/References:

[1]欧凤柳,胡艳丽,秦永.孕产妇宫颈病变筛查中高危HPVE6/E7mRNA与HPVDNA检测的临床价值[J].中国计划生育学杂志,2020,28(7):1060-1063. [2]Li Y,Rong S,Zhi Y,et al.Detection of cervical intraepithelial neoplasia with HPVE6/E7 mRNA among women with atypical squamous cells of unknown significance[J].Int J Gynaecol Obstet,2017,137(2):145-149.[3]赖婷,朱燕,陈琳,等.HPVE6/E7mRNA、p16、Ki-67在低级别宫颈鳞状上皮病变中的表达及意义[J].癌症进展,2020,18(2):168-171. [4]Velentzis LS,Smith MA,Simms KT,et al.Pathways to a cancer-free future: A protocol for modelled evaluations to maximize the future impact of interventions on cervical cancer in Australia[J].Gynecol Oncol,2019,152(3):465-471.[5]黄美园,杨珍玉,邓爽,等.高危型HPVE6/E7mRNA在不同年龄段宫颈病变筛查中的应用价值[J].临床与病理杂志,2020,40(5):1179-1184. [6]刘冬琴.HPVE6/E7 mRNA检测在宫颈癌早期病变中的表达及临床诊断价值分析[J].中国妇幼保健,2019,34(8):1747-1749. [7]周薇,代爱霞.宫颈高危HPV持续感染者脱落细胞中LncRNA NEAT1和HOTAIR的表达及临床意义[J].中国计划生育学杂志,2020,28(2):233-237.[8]Shen-Gunther J,Wang Y,Lai Z,et al.Deep sequencing of HPV E6/E7 genes reveals loss of genotypic diversity and gain of clonal dominance in high-grade intraepithelial lesions of the cervix[J].BMC Genomics,2017,18(1):231.[9]曾冰微,黄种心,张东妹.高危型HPV E6/E7 mRNA在宫颈病变筛查中的价值探讨[J].中国妇产科临床杂志,2018,19(1):9-11. [10]徐妹,金英杰,凌学民.人乳头瘤病毒(HPV)检查和宫颈液基薄层细胞学检测(TCT)联合阴道镜在筛查宫颈癌前病变中的应用价值探讨[J].影像研究与医学应用,2020,4(8):194-196.[11]陈标卫.HPV DNA、HPV E6/E7 mRNA检测在宫颈癌前病变筛查中的应用价值[J].广州医科大学学报,2018,46(6):44-47.[12]吴永茂,吴季兰,练惠织,等.HPV癌基因E6/E7mRNA在宫颈癌及癌前病变诊断中的临床价值[J].中国妇幼保健,2020,35(2):349-351. [13]黄珊珊,徐凤娟,成雁,等.高危型HPV E6/E7 mRNA与HC2 HPV-DNA联合检测在宫颈病变筛查中价值[J].中华实用诊断与治疗杂志,2020,34(6):577-580. [14]Rajasekaran N,Jung HS,Bae SH,et al.Effect of HPV E6/E7 siRNA with Chemotherapeutic Agents on the Regulation of TP53/E2F Dynamic Behavior for Cell Fate Decisions[J].Neoplasia,2017,19(10):735-749.[15]秦艳,朱怡.HPVE6/E7mRNA联合TCT检测在宫颈癌筛查的临床应用价值[J].中国妇幼健康研究,2020,31(5):665-670.

相似文献/References:

[1]徐淑华,郑圆花,余小燕.液基细胞学检查与高危型人乳头瘤病毒DNA检测在宫颈癌患者筛查中的临床价值[J].医学信息,2022,35(23):150.[doi:10.3969/j.issn.1006-1959.2022.23.032]
　XU Shu-hua,ZHENG Yuan-hua,YU Xiao-yan.The Clinical Value of Liquid-based Cytology and High-risk Human Papillomavirus DNA Detection in Cervical Cancer Screening[J].Medical Information,2022,35(22):150.[doi:10.3969/j.issn.1006-1959.2022.23.032]

更新日期/Last Update: 1900-01-01